Beth Seidenberg Biography and Net Worth

Dr. Beth C. Seidenberg, MD, is a Managing Director at Westlake Biopartners LLC, an Independent Director at Vera Therapeutics, Inc., an Independent Director at Atara Biotherapeutics, Inc., a Chairman at Progyny, Inc., a Chairman at Sagimet Biosciences, Inc. and a Partner & Advisor at Kleiner Perkins Caufield & Byers LLC. She is on the Board of Directors at Expansion Therapeutics, Inc., Vera Therapeutics, Inc., Atara Biotherapeutics, Inc., ACELYRIN, Inc., Arsenal Biosciences, Inc., Auxogyn, Inc., Breathe Technologies, Inc., Cell Design Labs, Inc., Kyverna Therapeutics, Inc., Mango Health, Inc., Spruce Health, Inc., Tmunity Therapeutics, Inc. and True North Therapeutics, Inc. Dr. Seidenberg was previously employed as an Independent Director by Epizyme, Inc., a Chief Medical Officer & SVP-Global Development by Amgen, Inc., a Senior Vice President-Global Development by Bristol Myers Squibb Co., a VP-Immunology, Pulmonary & Dermatology by Merck Research Laboratories Massachusetts LLC, a Chairman by Arresto BioSciences, Inc., a Chairman by Flexus Biosciences, Inc., a Senior Executive-Research & Development by Merck & Co., Inc., and a Researcher by National Institutes of Health. She also served on the board at Practice Fusion, Inc., ARMO BioSciences, Inc., Tesaro, Inc., BioCryst Pharmaceuticals, Inc., iPierian, Inc., Livongo Health, Inc., Rapt Therapeutics, Inc. and RedBrick Health Corp. She received her undergraduate degree from Barnard College and a doctorate degree from The University of Miami Leonard M. Miller School of Medicine.